Presynaptic endocytic machinery is constitutively deployed to periactive zones, indicating independent assembly pathways for the exo- and endocytic machineries of nerve terminals.

Revolune today announced the commercial availability of its multiplex immunofluorescence reagent portfolio and the official start of its commercialization journey. The milestone marks the company's ...

Background Most patients with biliary tract cancer (BTC) do not derive durable clinical benefit (DCB) from immune checkpoint inhibitors (ICIs), underscoring the urgent need for predictive biomarkers.

Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...

Apple introduced a new AI-powered photography tool at WWDC called Spatial Framing. Credit: Apple It was a big day for Apple Intelligence, Apple's distinctly branded suite of AI tools, at the company's ...

Understanding the tissue microenvironment in tumour samples is an important factor for predicting response to different treatment regimens. Highly multiplexed imaging of tenfolds of protein markers ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The move will bring hundreds of ...

LIVERMORE, Calif., & TAIPEI, Taiwan--(BUSINESS WIRE)--Syncell Inc., a leader in next-generation proteomics analysis, today announced the commercial launch of Syncell Discovery Services, a global ...

Addition of 18F-DCFPyL PSMA PET to MRI to avoid unnecessary biopsy in men on active surveillance: Final results from a phase II diagnostic trial (PROMPT). Clinical implications and diagnostic utility ...

Final results of a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin, and pazopanib: 2ND-STEP study, JCOG1802. Phase 1/2 study of ...

Disease-associated microglial states are thought to contribute to Alzheimer’s disease (AD) progression, but characterizing them and their relationships to pathology remains challenging. Here we ...

Orion HT and Orion LE extend the Orion platform from assay development through clinical trials, backed by an expanding biomarker reagent portfolio and commercial leadership focused on global growth ...